Neogen to report fiscal Q1 results October 6 with $0.05 EPS estimate

Verifying
  • Neogen is scheduled to report fiscal Q1 earnings on October 6, 2026.
  • Analysts expect adjusted EPS of $0.05 and revenue near $208 million.
  • FDA issued Neogen a warning letter as the company faces regulatory pressure.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.